Maryland Attorney General Anthony G. Brown joined a coalition of 22 states and the District of Columbia in urging the Supreme Court of the United States to block a lower court ruling that would restrict access to mifepristone, a medication commonly used for abortion and miscarriage care.
The coalition argues the ruling by the Fifth Circuit would reinstate an in-person dispensing requirement that had previously been removed by the U.S. Food and Drug Administration, limiting access to the medication through telehealth and mail delivery. The Supreme Court has issued a temporary administrative stay pausing the ruling while it considers emergency appeals.
The attorneys general contend the proposed restrictions are not supported by medical evidence and could create challenges for patients, particularly in rural and underserved areas, while increasing strain on healthcare systems in states where abortion remains legal. They also argue the decision could interfere with states’ authority to regulate reproductive healthcare and reduce access to a medication that has been widely used and studied for decades. The coalition is asking the Supreme Court to maintain access to mifepristone while the legal process continues.
